@prefix np: . @prefix npx: . @prefix ns1: . @prefix orcid: . @prefix prov: . @prefix rdf: . @prefix rdfs: . @prefix sub: . @prefix this: . @prefix xsd: . sub:Head { this: np:hasAssertion sub:assertion; np:hasProvenance sub:provenance; np:hasPublicationInfo sub:pubinfo; a np:Nanopublication . } sub:assertion { rdf:OBJECT rdfs:label "additional treatment" . rdf:OBJECT-POSITION rdfs:label "(19, 27)" . rdf:PREDICATE rdfs:label "received" . rdf:SUBJECT rdfs:label "patients" . rdf:SUBJECT-POSITION rdfs:label "(19, 27)" . ns1:receive ; rdfs:label "patients" . rdfs:label "treatment" . } sub:provenance { sub:_assertion prov:wasGeneratedBy "S&T TWOC Project - version 4" . sub:assertion prov:generatedAtTime "2023-06-12T11:58:37.153228"^^xsd:dateTime; prov:wasAttributedTo orcid:0000-0003-4692-1377 . rdf:Statement rdfs:label "34 out of 68 (50%) patients in the standard treatment group and 7 out of 90 (7.7%) in a cohort of patients who received additional treatment with tocilizumab once (either 400 mg intravenous or 324 mg subcutaneous) died." . rdfs:ABSTRACT-UID rdfs:label "6yhgtgzz" . rdfs:TRIPLE-UID rdfs:label "6yhgtgzz-TRIPLE-ABSTRACT-1" . } sub:pubinfo { sub:sig npx:hasAlgorithm "RSA"; npx:hasPublicKey "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"; npx:hasSignature "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"; npx:hasSignatureTarget this: . this: prov:wasAttributedTo orcid:0000-0003-4692-1377 . }